Find out more about who we are, what we do and the people behind Epitopea.
Find out what makes us unique and the work we do with our revolutionary CryptoMapTM platform.
All the latest company news, press releases and updates from Epitopea.
Contact

Epitopea Featured in Endpoints

February 19, 2025

Start­ up that mines ‘junk DNA ’ se­cures R&D deal with Mer­ck

By Ayisha Sharma, 19 February 2025

Epi­topea has inked a li­cense and re­search col­lab­o­ra­tion with Mer­ck to discov­er new tu­mor-spe­cific anti­gens from so-called “dark mat­ter” DNA, which are parts of the …

See Endpoints News for the full article

Related News

Epitopea Strengthens Scientific Advisory Board with Appointment of Leading Authority in Cancer, Lisa Butterfield

By admin on April 13, 2026
CAMBRIDGE, UK and MONTREAL, CANADA, 13 April 2026 — Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies […]
Read more

Epitopea Featured in GEN

By admin on April 1, 2026
Engineering Biology to Fight Cancer Solid tumors are heterogeneous with an immunosuppressive tumor microenvironment, but that is not slowing the […]
Read more

Epitopea Strengthens Scientific Advisory Board with Appointment of Four World Renowned Experts in Cancer Immunology and Immunotherapy

By admin on September 18, 2025
CAMBRIDGE, UK and MONTREAL, CANADA, 18 September 2025 – Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, […]
Read more
Revealing Novel Targets For Next Generation Immunotherapies
© 2022 – 2026 Epitopea Ltd | All Rights Reserved
Created by FDM Digital
arrow-down